Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection

Anaerobe. 2014 Dec:30:24-6. doi: 10.1016/j.anaerobe.2014.07.009. Epub 2014 Aug 5.

Abstract

An 85 year-old male initially admitted for septic shock due to urinary tract infection experienced Clostridium difficile-associated diarrhea during hospitalization and was treated by oral vancomycin. His clinical course was complicated by cytomegalovirus colitis and then vancomycin-resistant Clostridium innocuum bacteremia, which was cured by uneventfully parenteral piperacillin-tazobactam therapy.

Keywords: Clostridium difficile infection; Clostridium innocuum; Cytomegalovirus colitis; Oral vancomycin.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage*
  • Bacteremia / microbiology*
  • Clostridium / classification*
  • Clostridium / drug effects*
  • Clostridium / isolation & purification
  • Clostridium Infections / complications
  • Clostridium Infections / diagnosis
  • Clostridium Infections / drug therapy*
  • Clostridium Infections / microbiology
  • Cytomegalovirus Infections / diagnosis
  • Humans
  • Male
  • Penicillanic Acid / administration & dosage
  • Penicillanic Acid / analogs & derivatives
  • Piperacillin / administration & dosage
  • Piperacillin, Tazobactam Drug Combination
  • Treatment Outcome
  • Vancomycin / administration & dosage*
  • Vancomycin Resistance*

Substances

  • Anti-Bacterial Agents
  • Piperacillin, Tazobactam Drug Combination
  • Vancomycin
  • Penicillanic Acid
  • Piperacillin